10-Q: Universal Health Realty Income Trust Reports Q2 2026 Growth

Sentiment:

Quarterly Report


Universal Health Realty Income Trust announced its Q2 2026 results, showing an increase in net income and revenue, alongside strategic updates on its real estate portfolio and financing.

Capital raiseA shelf registration statement on Form S-3 was filed in April 2024, registering up to $100 million of common shares, preferred shares, and debt securities.As of June 30, 2026, no shares have been issued under this shelf registration statement.The company may issue securities under this registration statement depending on investor demand, market conditions, and other factors.The company believes it has sufficient capital resources for the next twelve months, but may access capital markets through borrowings under its Credit Agreement, refinancing of debt, issuance of long-term debt, or issuance of equity.

Summary

  • Universal Health Realty Income Trust (UHT) reported net income of $5.9 million for the three months ended June 30, 2026, an increase from $4.5 million in the same period of 2025.
  • For the six months ended June 30, 2026, net income was $10.9 million, up from $9.3 million in the prior year period.
  • Total revenues for the three months ended June 30, 2026, were $25.0 million, a slight increase from $24.9 million in the prior year period.
  • Total revenues for the six months ended June 30, 2026, were $49.5 million, a slight increase from $49.4 million in the prior year period.
  • The company completed the sale of a land parcel in Chicago, Illinois, for $746,000, generating a gain of $724,000.
  • Construction of the Miller Medical Plaza in Palm Beach Gardens, Florida, commenced in February 2026 and is expected to be completed in December 2026 with an estimated cost of $34 million.
  • The company's credit facility borrowing capacity was increased to $475 million from $425 million in April 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, with steady revenue growth and improved net income, though offset by increased interest expenses and ongoing reliance on a key tenant.

Positives

  • Net income increased by $1.4 million to $5.9 million for the three months ended June 30, 2026, compared to the prior year period.
  • Net income increased by $1.6 million to $10.9 million for the six months ended June 30, 2026, compared to the prior year period.
  • Total revenues showed a modest increase, reaching $25.0 million for the quarter and $49.5 million for the six-month period.
  • A gain of $724,000 was recognized from the sale of a land parcel in Chicago.
  • The borrowing capacity under the credit facility was increased to $475 million, providing greater financial flexibility.
  • Funds From Operations (FFO) increased to $12.5 million for the quarter and $24.8 million for the six-month period, indicating improved operational performance.
  • Interest expense decreased due to a lower average effective borrowing rate, contributing to improved net income.

Negatives

  • Despite revenue increases, the growth was marginal, indicating a slow pace of expansion.
  • Interest expense, while decreasing year-over-year, remains a significant expense, totaling $4.4 million for the quarter and $8.9 million for the six-month period.
  • The company's reliance on Universal Health Services (UHS) as a primary tenant continues, with UHS-related tenants comprising approximately 40% of consolidated revenues.
  • The company's tangible net worth requirement under its credit agreement was reduced from $125 million to $100 million, which could indicate a lower buffer or increased risk tolerance.
  • The company has $365.6 million in outstanding borrowings under its credit agreement as of June 30, 2026, representing a substantial portion of its available capacity.

Risks

  • Substantial portion of revenues are dependent upon one operator, UHS, which comprised approximately 40% of consolidated revenues.
  • UHS subsidiaries may not renew leases upon scheduled expiration, or may exercise purchase options, potentially decreasing future revenues.
  • Increased interest rates have significantly increased interest expense, reducing net income and impacting the ability to access capital markets on favorable terms.
  • Legislation like the 'One Big Beautiful Bill Act' may limit Medicaid enrollment and expenditures, potentially reducing tenant revenues and increasing uncompensated care.
  • Inflationary pressures and staffing shortages experienced by tenants could impact their ability and willingness to make rental payments.
  • Deterioration in national, regional, and local economic conditions could adversely affect the ability to obtain capital and refinance existing debt.
  • Heightened risk of future cybersecurity threats could have a material adverse effect on business operations and incur significant costs.
  • The outcome of known and unknown litigation, government investigations, and liabilities asserted against UHS could indirectly impact the Trust.

Future Outlook

The company believes its operating cash flows, cash and cash equivalents, available borrowing capacity under its Credit Agreement, and access to capital markets provide sufficient resources for the next twelve months, including funding capital expenditures, acquisitions, and dividend payments necessary to maintain REIT status. Future dividend levels will be determined based on projected operating cash flows and capital commitments.

Management Comments

  • The company's officers are all employees of a wholly-owned subsidiary of UHS.
  • UHS of Delaware, Inc. serves as the Advisor under an annually renewable Advisory Agreement.
  • All transactions between the Trust and UHS must be approved by Independent Trustees.
  • Management routinely monitors and analyzes the Trust's capital structure to maintain a targeted balance among capital resources.
  • The CEO and CFO have concluded that disclosure controls and procedures are effective.
  • There have been no changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

Industry Context

StockSavvy.ai notes that Universal Health Realty Income Trust operates within the specialized niche of healthcare real estate, a sector often characterized by long-term leases and stable tenant relationships, particularly with healthcare providers like UHS. The reported results reflect the general trend of modest revenue growth in this sector, with profitability influenced by interest rate environments and operational efficiencies.

Comparison to Industry Standards

  • The company's Funds From Operations (FFO) per diluted share for the quarter was $0.90, and $1.79 for the six-month period. These metrics are key for REITs, and their increase suggests positive operational performance relative to prior periods.
  • The advisory fee computation remained unchanged for 2026 as compared to 2025 and 2024, at 0.70% of average invested real estate assets, which appears to be within typical industry ranges for advisory services in REITs.
  • The company's total leverage ratio of 43.8% as of June 30, 2026, is within the <60% covenant, indicating a moderate level of debt relative to assets, which is generally considered prudent in the real estate sector.
  • The fixed charge coverage ratio of 3.5x is well above the minimum requirement of 1.50x, demonstrating a strong ability to cover its fixed obligations.

Legal Proceedings

  • UHS and its subsidiaries are subject to legal actions, purported shareholder class actions, shareholder derivative cases, governmental investigations, and regulatory actions.
  • Investors are encouraged to review disclosures in the Legal Proceedings section of Universal Health Services, Inc.'s Forms 10-Q and 10-K for potential indirect impacts.

Related Party Transactions

  • UHS of Delaware, Inc., a subsidiary of UHS, serves as the Advisor under an annually renewable Advisory Agreement.
  • The Trust's officers are all employees of a wholly-owned subsidiary of UHS.
  • Five hospital facilities are leased to UHS subsidiaries, one to a UHS joint venture, and nineteen medical/office buildings or free-standing emergency departments have UHS subsidiaries as tenants.
  • The aggregate revenues generated from UHS-related tenants comprised approximately 40% of consolidated revenues.
  • The Advisory Agreement was renewed for 2026 with the same terms as 2025 and 2024.
  • Advisory fees paid to UHS amounted to approximately $1.4 million for each three-month period and $2.8 million for each six-month period.
  • UHS owned 5.7% of the Trust's outstanding shares of beneficial interest as of June 30, 2026.

Stakeholder Impact

  • Shareholders benefit from increased net income and FFO, and continued dividend payments, though future dividend levels depend on various factors.
  • Employees of UHS, who also serve as the Trust's officers, are compensated through UHS and potentially stock-based awards from the Trust.
  • Tenants, primarily UHS subsidiaries, are subject to lease terms and potential rent increases, as well as broader economic and healthcare industry trends.
  • Creditors are subject to the terms of the Credit Agreement and mortgage notes, with covenants in place to ensure compliance and repayment.

Next Steps

  • Continue construction of the Miller Medical Plaza, expected to be completed in December 2026.
  • Monitor and manage interest rate risks through existing and potential future interest rate swap agreements.
  • Evaluate the impact of new accounting standards (ASU 2025-09 and ASU 2024-03) on financial statements and disclosures.
  • Continue to market remaining vacant properties in Chicago, Illinois, and Evansville, Indiana.
  • Manage compliance with covenants under the Credit Agreement and other debt obligations.
  • Determine future dividend levels based on projected operating cash flows and capital commitments.

Key Dates

DateDescription
1986-12-24Original Advisory Agreement with UHS of Delaware, Inc.
2019-01-01Restated Advisory Agreement with UHS of Delaware, Inc.
2024-04-30Form S-3 shelf registration statement became effective.
2025-12-31Expiration of current Advisory Agreement term (renewable).
2026-01-01Advisory Agreement renewed for 2026.
2026-02-01Construction commenced on Miller Medical Plaza.
2026-04-21First Amendment to Second Amended and Restated Credit Agreement entered into.
2026-06-30Quarterly period end for the reported financial statements.
2026-08-07Date of report signing.
2028-09-30Maturity date of the Credit Agreement.

Recommendation

hold

The filing shows steady performance with increased net income and FFO, and a strengthened credit facility. However, the continued high reliance on a single tenant (UHS), ongoing interest rate pressures, and the inherent risks in the healthcare real estate sector warrant a cautious 'hold' stance. While positive trends are present, significant catalysts for substantial upside are not immediately apparent from this report alone.

Keywords

Real Estate Investment Trust, Healthcare Facilities, Medical Office Buildings, Hospital Leases, Advisory Agreement, Interest Rate Swaps, Credit Facility, REIT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.